Analog vs Human Insulin Tied to Lower Death Risk in the Hemodialysis Population
Use of analog vs human insulin in patients receiving hemodialysis is associated with a lower risk for major adverse cardiovascular events, hospitalization, and death. Investigators compared analog and human insulin and major outcomes in patients with type 2 diabetes receiving hemodialysis.